XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Accounting standard adoption adjustment
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Deficit
Accounting standard adoption adjustment
Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Dec. 31, 2018     63,676,229 (2,681,285)        
Beginning Balance at Dec. 31, 2018 $ 170,729   $ 64 $ (3) $ 362,590 $ (187,491)   $ (4,431)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued upon exercise of stock options (in shares) 1,523,000   1,523,018          
Common stock issued upon exercise of stock options $ 16,918   $ 2   16,916      
Common stock issued upon vesting of restricted stock units (in shares)     1,197,576          
Common stock issued upon vesting of restricted stock units 1,000   $ 1   999      
Stock-based compensation 25,083       25,083      
Common stock issued under Employee Stock Purchase Plan (in shares)     146,250          
Common stock issued under Employee Stock Purchase Plan 4,142       4,142      
Common stock repurchase (in shares)       (28,545)        
Common stock repurchase (903)       (903)      
Equity component of convertible senior notes 52,900       52,900      
Equity component of convertible senior notes issuance costs 1,986       1,986      
Purchase of capped call option 23,184       23,184      
Bonus cash payment settled in shares of the Company’s common stock 0              
Net loss (96,071)         (96,071)    
Other comprehensive income (loss) (93)             (93)
Ending Balance (in shares) at Dec. 31, 2019     66,543,073 (2,709,830)        
Ending Balance at Dec. 31, 2019 $ 148,535 $ (729) $ 67 $ (3) 436,557 (283,562) $ (729) (4,524)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued upon exercise of stock options (in shares) 1,683,000   1,683,315          
Common stock issued upon exercise of stock options $ 21,354   $ 1   21,353      
Common stock issued upon vesting of restricted stock units (in shares)     915,827          
Common stock issued upon vesting of restricted stock units 1   $ 1          
Stock-based compensation 36,132       36,132      
Common stock issued under Employee Stock Purchase Plan (in shares)     118,637          
Common stock issued under Employee Stock Purchase Plan 4,002       4,002      
Equity component of convertible senior notes 162,534       162,534      
Equity component of convertible senior notes issuance costs 3,797       3,797      
Purchase of capped call option 46,058       46,058      
Common stock as earnout payment in connection with AdvantageTec Inc. (in shares)     11,508          
Stock Issued During Period, Value, Earnout Payment $ 293       293      
Bonus cash payment settled in shares of the Company's common stock (in shares) 991,905   991,905          
Bonus cash payment settled in shares of the Company’s common stock $ 24,657   $ 1   24,656      
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-13 [Member]              
Net loss $ (107,594)         (107,594)    
Other comprehensive income (loss) 4,604             4,604
Ending Balance (in shares) at Dec. 31, 2020     70,264,265 (2,709,830)        
Ending Balance at Dec. 31, 2020 $ 243,934   $ 70 $ (3) 635,672 (391,885)   80
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued upon exercise of stock options (in shares) 863,000   864,227          
Common stock issued upon exercise of stock options $ 11,701   $ 1   11,700      
Common stock issued upon vesting of restricted stock units (in shares)     1,058,361          
Common stock issued upon vesting of restricted stock units 0   $ 1   (1)      
Stock-based compensation 58,422       58,422      
Common stock issued under Employee Stock Purchase Plan (in shares)     95,136          
Common stock issued under Employee Stock Purchase Plan 4,409       4,409      
Common stock repurchase (in shares)     (30,344) (36,413)        
Common stock repurchase $ (709)       (709)      
Bonus cash payment settled in shares of the Company's common stock (in shares) 400,700   538,000          
Bonus cash payment settled in shares of the Company’s common stock $ 33,503   $ 1   33,502      
Issuance of common stock in connection with acquisitions (in shares)     2,130,213          
Issuance of common stock in connection with acquisitions 128,795   $ 2   128,793      
Net loss (124,974)         (124,974)    
Other comprehensive income (loss) (5,644)             (5,644)
Ending Balance (in shares) at Dec. 31, 2021     74,980,546 (2,746,243)        
Ending Balance at Dec. 31, 2021 $ 349,437   $ 75 $ (3) $ 871,788 $ (516,859)   $ (5,564)